CinnDromeX
En vente sur le marché américain (selon le DSLD)
XYMOGEN, food supplement from the US market
CinnDromeX (XYMOGEN), a food supplement au code-barres 871149001063, is described by its US market label, recorded on 24 October 2024. If sold in France, it would be subject to 3 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label, entered on 24 October 2024. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 200 µg a day according to the label (at most 1 serving a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/2340).
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 871149001063
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hypromellose, Water, Microcrystalline Cellulose, Stearic Acid, Magnesium Stearate, Silica, Medium Chain Triglyceride Oil
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Chromium | Mineral | 200 µg |
| American Ginseng Leaf, Root Extract (Panax quinquefolius) | Plant | 375 mg |
| Alpha-Lipoic Acid | Other substance | 200 mg |
| Green Tea Leaf Extract (Camellia sinensis) | Plant | 200 mg |
| Gymnema Leaf Extract (Gymnema sylvestre) | Plant | 200 mg |
| CinSulin | Plant | 200 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: CinnDromeX
Entered into DSLD on 18 July 2023. Retirée du marché américain le 8 September 2023 (selon le DSLD).- Same quantity, different name: American Ginseng Extract in this version; American Ginseng Leaf, Root Extract on the displayed label (375 mg)
- Same quantity, different name: CinSulin Cinnamon 10:1 aqueous extract in this version; CinSulin on the displayed label (200 mg)
Official label: CinnDromeX
Entered into DSLD on 23 April 2020. Retirée du marché américain le 18 August 2022 (selon le DSLD).- Active ingredient added : Cinnamon 10:1 aqueous extract (200 mg)
- Active ingredient added : Green Tea aqueous extract (200 mg)
- Active ingredient added : Gymnema extract (200 mg)
- Active ingredient removed : CinSulin (200 mg)
- Active ingredient removed : Green Tea Leaf Extract (200 mg)
- Active ingredient removed : Gymnema Leaf Extract (200 mg)
- Same quantity, different name: American Ginseng extract in this version; American Ginseng Leaf, Root Extract on the displayed label (375 mg)
Official label: CinnDromex
Entered into DSLD on 22 October 2016. Retirée du marché américain le 5 November 2018 (selon le DSLD).- Active ingredient added : Cinnamon 10:1 aqueous extract (200 mg)
- Active ingredient added : Green Tea aqueous extract (200 mg)
- Active ingredient added : Gymnema extract (200 mg)
- Active ingredient removed : CinSulin (200 mg)
- Active ingredient removed : Green Tea Leaf Extract (200 mg)
- Active ingredient removed : Gymnema Leaf Extract (200 mg)
- Same quantity, different name: American Ginseng extract in this version; American Ginseng Leaf, Root Extract on the displayed label (375 mg)
Official label: CinnDromeX
Entered into DSLD on 25 August 2015. Retirée du marché américain le 1 January 2015 (selon le DSLD).- Active ingredient added : Cinnamon (200 mg)
- Active ingredient added : Green Tea aqueous extract (200 mg)
- Active ingredient added : Gymnema extract (200 mg)
- Active ingredient removed : CinSulin (200 mg)
- Active ingredient removed : Green Tea Leaf Extract (200 mg)
- Active ingredient removed : Gymnema Leaf Extract (200 mg)
- Same quantity, different name: American Ginseng extract in this version; American Ginseng Leaf, Root Extract on the displayed label (375 mg)
- Different unit, without conversion : Chromium: 200 mg in this version; 200 mcg on the displayed label
Official label: CinnDromeX
Entered into DSLD on 25 April 2014. Retirée du marché américain le 24 February 2015 (selon le DSLD).- Active ingredient added : Cinnamon 10:1 aqueous extract (200 mg)
- Active ingredient added : Green Tea aqueous extract (200 mg)
- Active ingredient added : Gymnema extract (200 mg)
- Active ingredient removed : CinSulin (200 mg)
- Active ingredient removed : Green Tea Leaf Extract (200 mg)
- Active ingredient removed : Gymnema Leaf Extract (200 mg)
- Same quantity, different name: American Ginseng extract in this version; American Ginseng Leaf, Root Extract on the displayed label (375 mg)
Official label: CinnDromeX
Entered into DSLD on 23 March 2012. Retirée du marché américain le 10 July 2012 (selon le DSLD).- Same quantity, different name: American Ginseng in this version; American Ginseng Leaf, Root Extract on the displayed label (375 mg)
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : XYMOGEN